Showing results (1-10 of 139) with videos related to
Sort By:
Pageof 14
Annals of Nuclear Medicine|January 2, 2003
Neuroreceptor imaging in psychiatric disordersW Gordon Frankle, Marc LaruelleClinical Therapeutics|October 4, 2005
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitationMarc Laruelle, W Gordon Frankle, Rajesh Narendran, et al.Harvard Review of Psychiatry|October 10, 2007
Neuroreceptor imaging studies in schizophreniaW Gordon FrankleBiological Psychiatry|June 15, 2005
Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASBW Gordon Frankle, Rajesh Narendran, Yiyun Huang, et al.Synapse (New York, N.Y.)|December 18, 2004
Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humansPeter S Talbot, W Gordon Frankle, Dah-Ren Hwang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humansW Gordon Frankle, Yiyun Huang, Dah-Ren Hwang, et al.Biological Psychiatry|October 31, 2008
Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependenceDiana Martinez, Mark Slifstein, Roberto Gil, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methodsW Gordon Frankle, Mark Slifstein, Roger N Gunn, et al.Psychiatry Research|November 15, 2011
The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASBRagy R Girgis, Mark Slifstein, Xiaoyan Xu, et al.Current Opinion in Pharmacology|February 15, 2014
Schizophrenia: from dopaminergic to glutamatergic interventionsMarc LaruellePageof 14